---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-073638"
form_type: "8-K"
ticker: "CVRX"
cik: "0001235912"
company_name: "CVRx, Inc."
filed_at: "2025-08-04T23:59:59+00:00"
generated_at: "2026-05-17T21:22:21.996653+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# CVRx Q2 revenue up 15% to $13.6M; narrows FY25 guidance; names COO

## Summary
- Q2 2025 revenue $13.6M (+15% YoY); U.S. HF revenue $12.1M (+15%); net loss $14.7M ($0.57/share).
- Cash and equivalents $95.0M; net cash used in ops/investing $8.0M vs $10.2M prior year.
- Full-year 2025 revenue guidance narrowed to $55-57M (from $55-58M); Q3 2025 revenue expected $13.7-14.7M.
- CMS proposed keeping Barostim in APC 1580 for 2026 at ~$45,000 payment; Category I CPT codes set for Jan 2026.
- Appointed Brent Binkowski as COO effective Aug 11, 2025; base salary $405k, equity awards of 74,900 options and 16,600 RSUs.

## SEC filing metadata
- accession: 0001104659-25-073638
- form_type: 8-K
- ticker: CVRX
- cik: 0001235912
- company_name: CVRx, Inc.
- filed_at: 2025-08-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1235912/000110465925073638/0001104659-25-073638-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1235912/000110465925073638/tm2522379d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-073638
- JSON: https://secwatch.observer/filing/0001104659-25-073638.json
- Plain text: https://secwatch.observer/filing/0001104659-25-073638.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.
